Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Functional and in silico assessment of MAX variants of unknown significance.

Comino-Méndez I, Leandro-García LJ, Montoya G, Inglada-Pérez L, de Cubas AA, Currás-Freixes M, Tysoe C, Izatt L, Letón R, Gómez-Graña Á, Mancikova V, Apellániz-Ruiz M, Mannelli M, Schiavi F, Favier J, Gimenez-Roqueplo AP, Timmers HJ, Roncador G, Garcia JF, Rodríguez-Antona C, Robledo M, Cascón A.

J Mol Med (Berl). 2015 Nov;93(11):1247-55. doi: 10.1007/s00109-015-1306-y. Epub 2015 Jun 14.

PMID:
26070438
2.

MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.

Burnichon N, Cascón A, Schiavi F, Morales NP, Comino-Méndez I, Abermil N, Inglada-Pérez L, de Cubas AA, Amar L, Barontini M, de Quirós SB, Bertherat J, Bignon YJ, Blok MJ, Bobisse S, Borrego S, Castellano M, Chanson P, Chiara MD, Corssmit EP, Giacchè M, de Krijger RR, Ercolino T, Girerd X, Gómez-García EB, Gómez-Graña A, Guilhem I, Hes FJ, Honrado E, Korpershoek E, Lenders JW, Letón R, Mensenkamp AR, Merlo A, Mori L, Murat A, Pierre P, Plouin PF, Prodanov T, Quesada-Charneco M, Qin N, Rapizzi E, Raymond V, Reisch N, Roncador G, Ruiz-Ferrer M, Schillo F, Stegmann AP, Suarez C, Taschin E, Timmers HJ, Tops CM, Urioste M, Beuschlein F, Pacak K, Mannelli M, Dahia PL, Opocher G, Eisenhofer G, Gimenez-Roqueplo AP, Robledo M.

Clin Cancer Res. 2012 May 15;18(10):2828-37. doi: 10.1158/1078-0432.CCR-12-0160. Epub 2012 Mar 27.

3.

Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma.

Comino-Méndez I, Gracia-Aznárez FJ, Schiavi F, Landa I, Leandro-García LJ, Letón R, Honrado E, Ramos-Medina R, Caronia D, Pita G, Gómez-Graña A, de Cubas AA, Inglada-Pérez L, Maliszewska A, Taschin E, Bobisse S, Pica G, Loli P, Hernández-Lavado R, Díaz JA, Gómez-Morales M, González-Neira A, Roncador G, Rodríguez-Antona C, Benítez J, Mannelli M, Opocher G, Robledo M, Cascón A.

Nat Genet. 2011 Jun 19;43(7):663-7. doi: 10.1038/ng.861.

PMID:
21685915
4.

Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.

Qin N, de Cubas AA, Garcia-Martin R, Richter S, Peitzsch M, Menschikowski M, Lenders JW, Timmers HJ, Mannelli M, Opocher G, Economopoulou M, Siegert G, Chavakis T, Pacak K, Robledo M, Eisenhofer G.

Int J Cancer. 2014 Nov 1;135(9):2054-64. doi: 10.1002/ijc.28868. Epub 2014 Apr 7.

5.

MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours.

Crona J, Maharjan R, Delgado Verdugo A, Stålberg P, Granberg D, Hellman P, Björklund P.

Fam Cancer. 2014 Mar;13(1):121-5. doi: 10.1007/s10689-013-9666-3.

PMID:
23743562
6.

[Hereditary pheochromocytoma and paraganglioma: screening and follow-up strategies in asymptomatic mutation carriers].

Vermalle M, Tabarin A, Castinetti F.

Ann Endocrinol (Paris). 2018 Sep;79 Suppl 1:S10-S21. doi: 10.1016/S0003-4266(18)31234-4. Review. French.

PMID:
30213301
7.

Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients.

Calsina B, Currás-Freixes M, Buffet A, Pons T, Contreras L, Letón R, Comino-Méndez I, Remacha L, Calatayud M, Obispo B, Martin A, Cohen R, Richter S, Balmaña J, Korpershoek E, Rapizzi E, Deutschbein T, Vroonen L, Favier J, de Krijger RR, Fassnacht M, Beuschlein F, Timmers HJ, Eisenhofer G, Mannelli M, Pacak K, Satrústegui J, Rodríguez-Antona C, Amar L, Cascón A, Dölker N, Gimenez-Roqueplo AP, Robledo M.

Genet Med. 2018 Dec;20(12):1652-1662. doi: 10.1038/s41436-018-0068-7. Epub 2018 Jul 16.

PMID:
30008476
8.

Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes.

Pęczkowska M, Kowalska A, Sygut J, Waligórski D, Malinoc A, Janaszek-Sitkowska H, Prejbisz A, Januszewicz A, Neumann HP.

Clin Endocrinol (Oxf). 2013 Dec;79(6):817-23. doi: 10.1111/cen.12218. Epub 2013 May 3.

PMID:
23551045
9.

Structural aspects of interactions within the Myc/Max/Mad network.

Nair SK, Burley SK.

Curr Top Microbiol Immunol. 2006;302:123-43. Review.

PMID:
16620027
10.

Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients.

Cascón A, Inglada-Pérez L, Comino-Méndez I, de Cubas AA, Letón R, Mora J, Marazuela M, Galofré JC, Quesada-Charneco M, Robledo M.

Endocr Relat Cancer. 2013 May 30;20(3):L1-6. doi: 10.1530/ERC-12-0339. Print 2013 Jun. No abstract available.

PMID:
23404858
11.

The Mlx network: evidence for a parallel Max-like transcriptional network that regulates energy metabolism.

Billin AN, Ayer DE.

Curr Top Microbiol Immunol. 2006;302:255-78. Review.

PMID:
16620032
12.

Models of parent-of-origin tumorigenesis in hereditary paraganglioma.

Hoekstra AS, Devilee P, Bayley JP.

Semin Cell Dev Biol. 2015 Jul;43:117-124. doi: 10.1016/j.semcdb.2015.05.011. Epub 2015 Jun 9. Review.

PMID:
26067997
13.

Novel hereditary forms of pheochromocytomas and paragangliomas.

Dahia PL.

Front Horm Res. 2013;41:79-91. doi: 10.1159/000345671. Epub 2013 Mar 19. Review.

PMID:
23652672
14.

Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

Diolaiti D, McFerrin L, Carroll PA, Eisenman RN.

Biochim Biophys Acta. 2015 May;1849(5):484-500. doi: 10.1016/j.bbagrm.2014.05.016. Epub 2014 May 22. Review.

15.
16.

Pathological and Genetic Characterization of Bilateral Adrenomedullary Hyperplasia in a Patient with Germline MAX Mutation.

Romanet P, Guerin C, Pedini P, Essamet W, Castinetti F, Sebag F, Roche P, Cascon A, Tischler AS, Pacak K, Barlier A, Taïeb D.

Endocr Pathol. 2017 Dec;28(4):302-307. doi: 10.1007/s12022-016-9460-5.

17.

Pitfalls in genetic analysis of pheochromocytomas/paragangliomas-case report.

Canu L, Rapizzi E, Zampetti B, Fucci R, Nesi G, Richter S, Qin N, Giachè V, Bergamini C, Parenti G, Valeri A, Ercolino T, Eisenhofer G, Mannelli M.

J Clin Endocrinol Metab. 2014 Jul;99(7):2321-6. doi: 10.1210/jc.2013-4453. Epub 2014 Apr 23.

PMID:
24758185
18.

Max-E47, a designed minimalist protein that targets the E-box DNA site in vivo and in vitro.

Xu J, Chen G, De Jong AT, Shahravan SH, Shin JA.

J Am Chem Soc. 2009 Jun 10;131(22):7839-48. doi: 10.1021/ja901306q.

19.

Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and Erythrocytosis.

Korpershoek E, Koffy D, Eussen BH, Oudijk L, Papathomas TG, van Nederveen FH, Belt EJ, Franssen GJ, Restuccia DF, Krol NM, van der Luijt RB, Feelders RA, Oldenburg RA, van Ijcken WF, de Klein A, de Herder WW, de Krijger RR, Dinjens WN.

J Clin Endocrinol Metab. 2016 Feb;101(2):453-60. doi: 10.1210/jc.2015-2592. Epub 2015 Dec 15.

PMID:
26670126
20.

Improving the thermodynamic stability of the leucine zipper of max increases the stability of its b-HLH-LZ:E-box complex.

Jean-François N, Frédéric G, Raymund W, Benoit C, Lavigne P.

J Mol Biol. 2003 Mar 7;326(5):1577-95.

PMID:
12595267

Supplemental Content

Support Center